These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29449101)

  • 1. Evaluation of a convenient vaccination schedule against hepatitis B in HIV-patients with undetectable HIV viral load.
    Kourkounti S; Retsas T; Paparizos V; Tsimpidakis A; Kapsimali V; Rigopoulos D
    Vaccine; 2018 Mar; 36(12):1533-1536. PubMed ID: 29449101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults.
    Potsch DV; Camacho LA; Tuboi S; Villar LM; Miguel JC; Ginuíno C; Silva EF; Mendonça RM; Moreira RB; Barroso PF
    Vaccine; 2012 Sep; 30(41):5973-7. PubMed ID: 22828589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
    Bailey CL; Smith V; Sands M
    Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B Virus Vaccination in HIV: Immunogenicity and Persistence of Seroprotection up to 7 Years Following a Primary Immunization Course.
    Nicolini LA; Magne F; Signori A; Di Biagio A; Sticchi L; Paganino C; Durando P; Viscoli C
    AIDS Res Hum Retroviruses; 2018 Nov; 34(11):922-928. PubMed ID: 29926738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
    Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
    Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load.
    Rey D; Krantz V; Partisani M; Schmitt MP; Meyer P; Libbrecht E; Wendling MJ; Vetter D; Nicolle M; Kempf-Durepaire G; Lang JM
    Vaccine; 2000 Jan; 18(13):1161-5. PubMed ID: 10649616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.
    O'Bryan TA; Rini EA; Okulicz J; Messner O; Ganesan A; Lalani T; Bavaro MF; O'Connell RJ; Agan BK; Landrum ML
    HIV Med; 2015 Mar; 16(3):161-7. PubMed ID: 25586899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination Against Hepatitis B Virus (HBV) in HIV-1-Infected Patients With Isolated Anti-HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective Study.
    Piroth L; Launay O; Michel ML; Bourredjem A; Miailhes P; Ajana F; Chirouze C; Zucman D; Wendling MJ; Nazzal D; Carrat F; Rey D; Binquet C;
    J Infect Dis; 2016 Jun; 213(11):1735-42. PubMed ID: 26768256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults.
    Cooper CL; Davis HL; Angel JB; Morris ML; Elfer SM; Seguin I; Krieg AM; Cameron DW
    AIDS; 2005 Sep; 19(14):1473-9. PubMed ID: 16135900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects.
    Potsch DV; Oliveira ML; Ginuíno C; Miguel JC; Oliveira SA; Silva EF; Moreira RB; Cruz GV; Oliveira AL; Camacho LA; Barroso PF
    Vaccine; 2010 Feb; 28(6):1447-50. PubMed ID: 19995540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to a reinforced hepatitis B vaccination scheme in HIV-infected patients under real-life conditions.
    Neukam K; Gutiérrez-Valencia A; Llaves-Flores S; Espinosa N; Viciana P; López-Cortés LF
    Vaccine; 2019 May; 37(20):2758-2763. PubMed ID: 30981625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus vaccination in HIV-infected people: A review.
    Catherine FX; Piroth L
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-10. PubMed ID: 28267387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Efficacy of a High-Dose vs Standard-Dose Hepatitis B Revaccination Schedule Among Patients With HIV: A Randomized Clinical Trial.
    Vargas JI; Jensen D; Martínez F; Sarmiento V; Peirano F; Acuña P; Provoste F; Bustos V; Cornejo F; Fuster A; Acuña M; Fuster F; Soto S; Estay D; Jensen W; Ahumada R; Arab JP; Soza A; Fuster F
    JAMA Netw Open; 2021 Aug; 4(8):e2120929. PubMed ID: 34424307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological response to hepatitis B vaccination in patients with AIDS and virological response to highly active antiretroviral therapy.
    Paitoonpong L; Suankratay C
    Scand J Infect Dis; 2008; 40(1):54-8. PubMed ID: 17852939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does increased hepatitis B vaccination dose lead to a better immune response in HIV-infected patients than standard dose vaccination: a meta-analysis?
    Ni JD; Xiong YZ; Wang XJ; Xiu LC
    Int J STD AIDS; 2013 Feb; 24(2):117-22. PubMed ID: 23467291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of immunity in healthy adults aged ≥ 50 years primed with a hepatitis B vaccine 3 years previously.
    Sharma R; Ahlm C; Ostergaard L; Dowell A; Tran C; Thomas S; Eymin C
    Hum Vaccin Immunother; 2015; 11(7):1709-16. PubMed ID: 25996838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4/CD8 ratio as a predictor of the response to HBV vaccination in HIV-positive patients: A prospective cohort study.
    Fuster F; Vargas JI; Jensen D; Sarmiento V; Acuña P; Peirano F; Fuster F; Arab JP; Martínez F;
    Vaccine; 2016 Apr; 34(16):1889-95. PubMed ID: 26945101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with seroconversion after standard dose hepatitis B vaccination and high-dose revaccination among HIV-infected patients.
    Pettit NN; DePestel DD; Malani PN; Riddell J
    HIV Clin Trials; 2010; 11(6):332-9. PubMed ID: 21239361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania.
    Pippi F; Bracciale L; Stolzuoli L; Giaccherini R; Montomoli E; Gentile C; Filetti S; De Luca A; Cellesi C
    HIV Med; 2008 Aug; 9(7):519-25. PubMed ID: 18554311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the immunological response to hepatitis B vaccination in HIV-infected patients in clinical practice.
    Mena G; Llupià A; García-Basteiro AL; Díez C; León A; García F; Bayas JM
    Vaccine; 2012 May; 30(24):3703-9. PubMed ID: 22446635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.